GRS Home

The Growth Hormone Research Society

Pituitary

16th GRS Workshop

The GH Research Society held its 16th Workshop on the topic of Safety of GH Treatment in Cancer and Intracranial Tumor Survivors in Children and Adults.

This invitation-only workshop was performed through a web-based platform. We had adapted the schedule of this web-based structure with short online meetings taking place on three different occasions last year (June 9th and 16th, and September 29th). The workshop was organized with the support of the European Society of Endocrinology. Other major endocrine societies had also been invited to nominate delegates to the workshop.

Additionally, representatives from the regulatory agencies, EMA and FDA, attended. A review paper on the topic had been written by members of the program organizing committee, and it was distributed to the delegates prior to the start of the meeting. The format of each workshop had been modified over the years, but the backbone of plenary lectures set the scene followed by breakout group discussions of more specific themes or questions.

The final session was devoted to drafting a statement summarizing the outcome of the workshop that was submitted for publication. GRS had published the results of its previous 15 workshops that had ‘stood the test of time’.

Consensus Statements


The GRS sponsors consensus statements on GH-related issues. These consensus statements shown below can be downloaded as pdf files (with permission from the publisher) and viewed using Adobe Acrobat Reader v.5.0 or greater. The pdf files include a list of the participants in the consensus workshops.

Safety of Growth Hormone Replacement in Survivors of Cancer and Intracranial and Pituitary Tumours: A Consensus Statement.pdf
Eur J Endocrinol. 2022 Apr 21;186(6):35-52. doi: 10.1530/EJE-21-1186.
2022 Online:

Diagnosis, Genetics, and Therapy of Short Stature in Children: A Growth Hormone Research Society International Perspective.pdf
Horm Res Paediatr. 2019 Sep 12:1-14. doi: 10.1159/000502231. [Epub ahead of print]
2019 Lisbon, Portugal:

Growth Hormone Research Society perspective on biomarkers of GH action in children and adults.pdf
Endocr Connect. 2018 Mar;7(3):R126-R134)
2017 Aarhus, Denmark:

Growth Hormone Research Society perspective on the development of long-acting growth hormone preparations.pdf
Eur J Endocrinol. 2016 Jun;174(6):C1-8. doi: 10.1530/EJE-16-0111. Epub 2016 Mar 23.
2015 Pacific Grove, California, USA:

Growth Hormone Safety Workshop Position Paper: a critical appraisal of recombinant human growth hormone therapy in children and adults.pdf
Eur J Endocrinol. 2015 Nov 12. pii: EJE-15-0873. [Epub ahead of print]
2014 Manchester, England:

Growth Hormone Research Society workshop summary: consensus guidelines for recombinant human growth hormone therapy in Prader-Willi syndrome.pdf
J Clin Endocrinol Metab. 2013 Jun;98(6):E1072-87
2011 Montreal, Canada:

Consensus Statement on the Standardization and Evaluation of Growth Hormone and Insulin-like Growth Factor Assays.pdf
Clin. Chem. 57: 555-559, 2011
2009 Keswick, Virginia, USA:

Statement by the Growth Hormone Research Society on the GH/IGF-I Axis in Extending Health Span.pdf
J Gerontol A Biol Sci Med Sci 64A: 1039-1044, 2009
2008 Reykjavik, Iceland:

Consensus guidelines for the diagnosis and treatment of adults with GH deficiency II: a statement of the GH Research Society in association with the European Society for Pediatric Endocrinology, Lawson Wilkins Society, European Society of Endocrinology, Japan Endocrine Society, and Endocrine Society of Australia.pdf
Eur J Endocrinol 157: 695-700, 2007
2007 Sydney, Australia:

Consensus Statement on the Diagnosis and Treatment of Children with Idiopathic Short Stature: A Summary of the Growth Hormone Research Society, the Lawson Wilkins Pediatric Endocrine Society, and the European Society for Paediatric Endocrinology Workshop.pdf
J Clin Endocrinol Metab 93: 4210?4217, 2008
2007 Santa Monica, California, USA:

Management of the Child Born Small for Gestational Age through to Adulthood: A Consensus Statement of the International Societies of Pediatric Endocrinology and the Growth Hormone Research Society.pdf
J Clin Endocrinol Metab 92: 2006-2017, 2007
2006 Manchester, UK:

Consensus statement on the management of the GH-treated adolescent in the transition to adult care.pdf
Eur J Endocrinol 152:165-170, 2005
2003 Manchester, UK:

Biochemical Assessment and Long-Term Monitoring in Patients with Acromegaly: Statement from a Joint Consensus Conference of The Growth Hormone Research Society and The Pituitary Society.pdf
J Clin Endocrinol Metab 89: 3099-3102, 2004
2003: Feldafing, Germany:

Critical Evaluation of the Safety of Recombinant Human Growth Hormone Administration: Statement from the Growth Hormone Research Society.pdf
J Clin Endocrinol Metab 86: 1868?1870, 2001
2000: Keswick, Virginia, USA:
The consensus can also be presented with the following: Keswick.ppt.

Consensus Guidelines for the Diagnosis and Treatment of Growth Hormone (GH) Deficiency in Childhood and Adolescence: Summary Statement of the GH Research Society.pdf
J Clin Endocrinol Metab 83: 3990?3993, 2000
1999: Eilat, Israel:
The consensus can also be presented with the following: Eilat.ppt

Consensus Guidelines for the Diagnosis and Treatment of Adults with Growth Hormone Deficiency: Summary Statement of the Growth Hormone Research Society Workshop on Adult Growth Hormone Deficiency.pdf
J Clin Endocrinol Metab 83: 379?381, 1998
1997: Port Stevens, New South Wales, Australia:
The consensus can also be presented with the following: Stephen6.ppt

 

 

Constitution

 

Consensus Statements

 

Honorary Members

 

hGH Indications

 

Officers

IGF Society

Links